Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model.
Level 5 - mechanism / opinion, no new human data
Narrative conceptual review synthesizing literature to propose a theoretical model without new human data
PubMed 25585035 · doi:10.1176/appi.ajp.2014.14070918
What was done
This conceptual review synthesized existing literature on perimenopausal depression epidemiology, predictors, and estrogen therapy, alongside findings from animal models and clinical research in other reproductive mood disorders, to construct a heuristic mechanistic model.
What was found
The authors report that rates of major depressive disorder and clinically meaningful depressive symptoms increase two- to threefold during the menopause transition. Based on literature synthesis, the authors propose that fluctuating ovarian hormones and derived neurosteroids alter GABAergic regulation of the hypothalamic-pituitary-adrenal (HPA) axis, specifically via failure of GABAA receptors to maintain tone, thereby increasing stress sensitivity and depressive vulnerability. No original empirical data or pooled statistics were presented.
Why it matters
It provides an organizing neurobiological framework linking endocrine fluctuations to GABAergic and HPA axis stress dysregulation in midlife depression, generating testable hypotheses for targeted pharmacological interventions.
Limits
The paper is a narrative conceptual review with no primary empirical human data and no systematic review methodology. The proposed neurobiological pathways represent hypothesis-generating mechanism-based reasoning that requires direct prospective clinical validation.
Cited by
- supports Steroid hormone changes during perimenopause and menopause alter neural circuit activities in brain regions like the hypothalamus and the hypothalamic-pituitary-adrenal axis.